GLENN L MD COOPER Insider Trading
Get free email notifications about insider trading for GLENN L MD COOPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN L MD COOPER. GLENN L MD COOPER is a President and CEO in Endo Pharmaceuticals Solutions Inc. ($IDEV) and a Director in REPLIGEN CORP ($RGEN).
Address: INDEVUS PHARMACEUTICALS, INC. 99 HAYDEN AVENUE LEXINGTON 02421 MA
Companies in which GLENN L MD COOPER is an Insider
Endo Pharmaceuticals Solutions Inc.
Trading Symbol: IDEVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GLENN L MD COOPER: President and CEO
Holdings: 185,000 shares
Latest Transaction: Mar 11 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REPLIGEN CORP
Trading Symbol: RGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GLENN L MD COOPER: Director
Holdings: 35,975 shares
Current Value: $1,051,909
Latest Transaction: May 28 2019
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GLENN L MD COOPER
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Sell | S | 67.53 | 266 | 17,963 | 35,709 | 36 K to 35.7 K (-0.74 %) |
May 28 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Sell | S | 66.91 | 4,734 | 316,752 | 35,975 | 40.7 K to 36 K (-11.63 %) |
May 17 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 67.71 | 2,109 | 142,800 | 2,109 | |
May 17 2019 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 923 | 0 | 40,709 | 39.8 K to 40.7 K (+2.32 %) |
May 17 2018 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 42.07 | 3,304 | 138,999 | 3,304 | |
May 17 2018 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Grant | A | 0.00 | 1,486 | 0 | 39,786 | 38.3 K to 39.8 K (+3.88 %) |
May 22 2017 | RGEN | REPLIGEN CORP | COOPER GLENN L MD | Director | Option Exercise | A | 38.76 | 2,434 | 94,342 | 2,434 |